Skip to content
Screener

Elicio Therapeutics, Inc. ELTX Q4 2024 Annual earnings

Reported March 31, 2025 · Before market open

Revenue$1.2M
EPS-$1.02Miss by $0.08
EPS estimate-$0.94

Next report

Date not yet announced

FAQ

When did Elicio Therapeutics, Inc. report Q4 2024 earnings?
Elicio Therapeutics, Inc. (ELTX) reported Q4 2024 earnings on March 31, 2025 before market open.
What were Elicio Therapeutics, Inc.'s Q4 2024 revenue and EPS?
Elicio Therapeutics, Inc. reported revenue of $1.2M and eps of $-1.02 for Q4 2024.
Did Elicio Therapeutics, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.94 by $0.08.
Where can I find Elicio Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 8-K earnings release (0001601485-25-000046) and the 10-K periodic report (0001601485-25-000049) directly on SEC EDGAR. The filing index links above go to sec.gov.